New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy.

Abstract excerpt

Hypertrophic cardiomyopathy is caused by mutations in genes encoding sarcomeric proteins. Its variable phenotype suggests the existence of modifier genes. Myocyte enhancer factor (MEF) 2C could be important in this process given its role as transcriptional regulator of several cardiac genes. Any variant affecting MEF2C expression and/or function may impact on hypertrophic cardiomyopathy clinical manifestations....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 5' Untranslated Regions
• Share to Cardiomyopathy, Hypertrophic